|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 |
| (11) | Patento numeris | 3209691 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15794641.9 |
| Europos patento paraiškos padavimo data | 2015-10-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/058124 |
| Data | 2015-10-21 |
| (87) | Numeris | WO 2016/063233 |
| Data | 2016-04-28 |
| (30) | Numeris | Data | Šalis |
| 14190370 | 2014-10-24 | EP |
| (72) |
POIRIER, Nicolas, FR
VANHOVE, Bernard, FR
|
| (73) |
OSE Immunotherapeutics,
22 Boulevard Benoni Goullin, 44200 Nantes,
FR
|
| (54) | COMPOSITIONS FOR INDUCING DIFFERENTIATION OF MYELOID DERIVED SUPPRESSOR CELL TO TREAT CANCER AND INFECTIOUS DISEASES |
| COMPOSITIONS FOR INDUCING DIFFERENTIATION OF MYELOID DERIVED SUPPRESSOR CELL TO TREAT CANCER AND INFECTIOUS DISEASES |